Question explored with the scientific record
Does salt cause or help hypertension?
The short version: the evidence is clear that salt raises blood pressure in most people, and reducing it lowers blood pressure, but the effect size is modest and varies by individual.
The evidence here is unusually solid for a nutrition question. Multiple randomized controlled trials, including the DASH-Sodium trial with 412 participants on controlled feeding, show that reducing salt intake lowers systolic blood pressure by about 4-5 mmHg in people with hypertension and 1-2 mmHg in those without [1, 6]. The effect is dose-dependent: the more you cut salt, the more blood pressure drops [1, 6]. A 2023 crossover trial of 213 adults found that switching from a high-sodium diet (~2200 mg/day) to a low-sodium diet (~500 mg/day) for one week lowered mean arterial pressure by about 4 mmHg, with 73% of participants experiencing a drop [3]. A meta-analysis of 16 RCTs on potassium-enriched salt substitutes found a 5.1 mmHg systolic reduction and an 11% reduction in all-cause mortality [3]. The DECIDE-Salt trial in elderly care facilities, a cluster RCT of 1,612 people, showed a 7.1 mmHg systolic drop and a 2.3% reduction in major cardiovascular events [3]. The evidence is not funded by a single manufacturer with a patent to protect; it comes from independent academic and government sources.
The controversy is real but overblown. Some observational studies, like Alderman et al. 1991, found that very low sodium intake was associated with higher heart attack risk in treated hypertensive men [6]. This is a J-shaped curve: both very high and very low sodium may be harmful, but the sweet spot is well below the typical Western intake of 9-12 g/day [4]. The WHO target of 5 g/day is supported by the bulk of the trial evidence [4]. The mechanism is straightforward: sodium holds water in the blood vessels, increasing volume and pressure. The effect is larger in people who are "salt-sensitive," which includes older adults, people with kidney disease, and those of African descent [1, 6]. For a healthy person eating a standard Western diet, cutting salt is a low-risk, low-cost intervention with a modest but real benefit.
| Population | Systolic BP reduction from moderate salt reduction | Source |
|---|---|---|
| Hypertensive adults | 4-5 mmHg | [1, 6] |
| Normotensive adults | 1-2 mmHg | [1, 6] |
| Children (meta-analysis, 10 trials) | 1.2 mmHg | [8] |
| Elderly in care facilities (salt substitute) | 7.1 mmHg | [3] |
My call: for most people, reducing dietary salt from the typical 9-12 g/day toward 5 g/day will lower blood pressure by a modest but meaningful amount, especially if you already have hypertension.
Sources examined 12
-
Salt and Blood Pressure: Time to Challenge
A comprehensive synthesis of epidemiological, experimental, genetic, and clinical trial evidence showing that high dietary salt elevates blood pressure and that modest salt reduction lowers BP in both hypertensive and normotensive individuals, with DASH-Sodium and population-wid…
DOI: 10.1159/000088265 -
Impact of self-monitoring of salt intake by salt meter in hypertensive patients: a randomised controlled trial (SMAL-SALT)
In hypertensive patients, self-monitoring of salt intake with a salt meter plus dietary education led to greater salt reduction, better blood pressure control, and increased motivation to maintain a low-salt diet compared with education alone over 8 weeks in a randomized control…
DOI: 10.1093/ehjci/ehaa946.2766 -
Nutrition and Hypertension Researches in 2023: focus on salt intake and blood pressure
A concise mini-review summarizing 2023 nutrition-related hypertension research with a focus on salt intake, salt reduction strategies, and their BP outcomes, including notable trials, meta-analyses, and metabolomic insights within the DASH framework and public health contexts.
DOI: 10.1038/s41440-024-02089-5 -
The health impacts of dietary sodium and a low-salt diet
A comprehensive narrative review of global salt and sodium intake, its links to hypertension and cardiovascular disease, and the rationale for population‑level salt reduction to meet WHO targets, with discussion of mechanisms, measurement, and policy implications.
DOI: 10.7861/clinmedicine.15-6-585 -
Effectiveness of self‐management support in maintenance haemodialysis patients with hypertension: A pilot cluster randomized controlled trial
A cluster randomized trial in a Beijing haemodialysis center shows that a focused self-management support program (education + motivational interviewing) modestly improves pre-dialysis blood pressure, salt intake, home blood pressure monitoring consistency, and medication adhere…
DOI: 10.1111/nep.13098 -
Dietary salt reduction in hypertension—What is the evidence and why is it still controversial?
A comprehensive review of the evolving evidence on dietary salt reduction and hypertension, summarizing historical ecological and modern population studies, salt sensitivity, and interventional trials/meta-analyses that show modest blood pressure reductions in hypertensive indiv…
DOI: 10.1016/s0033-0620(99)70007-1 -
Role of Dietary Salt and Potassium Intake in Cardiovascular Health and Disease: A Review of the Evidence
This review synthesizes evidence on the impact of dietary salt and potassium intake on blood pressure, cardiovascular disease, and mortality, advocating for population-wide sodium reduction and increased potassium intake as essential public health measures.
DOI: 10.1016/j.mayocp.2013.06.005 -
Importance of Salt in Determining Blood Pressure in Children
A comprehensive meta-analysis of controlled trials in children and infants showing that modest dietary salt reduction lowers blood pressure, with quantified small decreases in systolic and diastolic BP and implications for cardiovascular risk reduction.
DOI: 10.1161/01.HYP.0000245672.27270.4a -
The double challenge of resistant hypertension and chronic kidney disease
Resistant hypertension coexists with chronic kidney disease (CKD) and presents substantial clinical challenges due to inconsistent definitions and limited high-quality evidence guiding effective management, underscoring the need for standardized criteria and targeted trials.
DOI: 10.1016/S0140-6736(15)00418-3 -
Substantial and Sustained Improvements in Blood Pressure, Weight and Lipid Profiles from a Carbohydrate Restricted Diet: An Observational Study of Insulin Resistant Patients in Primary Care
An observational, real-world cohort study in UK primary care assessing the effects of a carbohydrate-restricted diet on blood pressure, weight, and lipid profiles in insulin-resistant patients with type 2 diabetes or impaired glucose tolerance, showing substantial and sustained …
DOI: 10.3390/ijerph16152680 -
The efficacy of a low-sodium salt substitute enriched with potassium to improve sodium-to-potassium ratio and reduce blood pressure in adolescents and their families in Soweto, South Africa: study protocol for randomised controlled trial
A phase 1, double-blind randomized controlled trial in Soweto, South Africa assessing whether a 50% potassium-enriched, low-sodium salt substitute improves urinary sodium-to-potassium ratio and reduces blood pressure in adolescents and their households, while evaluating safety, …
DOI: 10.1186/s13063-025-09184-z -
Effects of Calcium Channel and Renin-Angiotensin System Blockade on Intravascular and Neurohormonal Mechanisms of Hypertensive Vascular Disease
A comprehensive review arguing that combined calcium-channel blockade and renin-angiotensin system blockade provides vascular benefits beyond brachial blood pressure by improving central arterial pressure, reducing arterial stiffness, and enhancing endothelial nitric oxide bioav…
DOI: 10.1038/ajh.2008.258